CME Credit

To obtain a CME credit:

1. Listen to Talking ADHD Program 1 – A Transdermal Methylphenidate Delivery System and, if you wish, view the accompanying materials online
2. At the conclusion of the activity, go to www.cecentral.com/getcredit             
3. Enter the program code: MEN07039                
4. Follow the online instructions to obtain credit

NEEDS ASSESSMENT

Currently there are significant barriers to effective diagnosis and treatment of ADHD: the majority of physicians involved in managing the condition are under-educated as to diagnosis and treatment. A range of medications are available, but it can be difficult to determine the optimal and most acceptable treatment for individual patients, especially when adherence is such a problem. Therefore, education on prescribing, monitoring, and titrating these medications is imperative for appropriate treatment and better patient outcomes.

This program will address the use of transdermal patches for the delivery of the ADHD medication methylphenidate. This transdermal delivery system, introduced earlier this year, is the first of its kind to reach the market, and physicians contemplating its use need to have a full understanding of the purported benefits of this approach and issues surrounding management of the patch, including associated side effects.

GOAL

To inform the audience about the indications, utility, and issues surrounding the use of transdermal drug delivery systems in ADHD.

LEARNING OBJECTIVES

Upon completion of this activity, participants should be able to describe the performance, safety, availability, benefits, and challenges connected with the transdermal methylphenidate delivery system for ADHD.

DISCLOSURE STATEMENTS